Abner Herrman & Brock LLC Abb Vie Inc. Transaction History

Abner Herrman & Brock LLC

$829 Million
Q3 2024

A detailed history of Abner Herrman & Brock LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Abner Herrman & Brock LLC holds 4,177 shares of ABBV stock, worth $722,704. This represents 0.1% of its overall portfolio holdings.

Number of Shares

4,177

Previous 4,177 -0.0%

Holding current value

$722,704

Previous $717,000 15.06%

% of portfolio

0.1%

Previous 0.09%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$163.84 - $199.33 $684,359 - $832,601	4,177 New	4,177 $825,000
Q2 2024 Jul 18, 2024	BUY	$154.79 - $180.76 $646,557 - $755,034	4,177 New	4,177 $717,000
Q1 2024 Apr 09, 2024	BUY	$159.82 - $182.1 $8,790 - $10,015	55 Added 1.36%	4,089 $745,000
Q4 2023 Jan 09, 2024	SELL	$137.6 - $154.97 $50,499 - $56,873	-367 Reduced 8.34%	4,034 $625,000
Q3 2023 Oct 10, 2023	SELL	$133.59 - $154.65 $61,184 - $70,829	-458 Reduced 9.43%	4,401 $656,000
Q2 2023 Jul 05, 2023	SELL	$132.51 - $164.9 $182,201 - $226,737	-1,375 Reduced 22.06%	4,859 $655,000
Q1 2023 Apr 13, 2023	BUY	$144.61 - $166.54 $723 - $832	5 Added 0.08%	6,234 $994,000
Q4 2022 Jan 04, 2023	SELL	$138.31 - $165.87 $6,915 - $8,293	-50 Reduced 0.8%	6,229 $1.01 Million
Q3 2022 Oct 06, 2022	SELL	$134.21 - $153.93 $4,160 - $4,771	-31 Reduced 0.49%	6,279 $843,000
Q2 2022 Jul 13, 2022	BUY	$137.62 - $174.96 $221,292 - $281,335	1,608 Added 34.2%	6,310 $966,000
Q1 2022 Apr 07, 2022	SELL	$131.98 - $163.75 $11,218 - $13,918	-85 Reduced 1.78%	4,702 $762,000
Q4 2021 Jan 13, 2022	BUY	$107.43 - $135.93 $50,814 - $64,294	473 Added 10.96%	4,787 $648,000
Q3 2021 Oct 06, 2021	BUY	$106.4 - $120.78 $4,788 - $5,435	45 Added 1.05%	4,314 $465,000
Q2 2021 Jul 09, 2021	SELL	$105.21 - $117.21 $43,136 - $48,056	-410 Reduced 8.76%	4,269 $481,000
Q1 2021 Apr 09, 2021	SELL	$102.3 - $112.62 $324,393 - $357,118	-3,171 Reduced 40.39%	4,679 $506,000
Q4 2020 Jan 12, 2021	SELL	$80.49 - $108.67 $4,024 - $5,433	-50 Reduced 0.63%	7,850 $841,000
Q2 2020 Jul 10, 2020	BUY	$73.37 - $98.18 $5,209 - $6,970	71 Added 0.91%	7,900 $776,000
Q1 2020 Apr 09, 2020	SELL	$64.5 - $97.79 $45,150 - $68,453	-700 Reduced 8.21%	7,829 $596,000
Q4 2019 Jan 10, 2020	BUY	$72.13 - $90.25 $108,195 - $135,375	1,500 Added 21.34%	8,529 $755,000
Q3 2019 Oct 11, 2019	SELL	$62.98 - $75.72 $349,539 - $420,246	-5,550 Reduced 44.12%	7,029 $532,000
Q2 2019 Jul 19, 2019	BUY	$65.7 - $83.98 $358,065 - $457,691	5,450 Added 76.45%	12,579 $915,000
Q1 2019 Apr 08, 2019	BUY	$77.14 - $90.79 $14,039 - $16,523	182 Added 2.62%	7,129 $575,000
Q4 2018 Jan 11, 2019	BUY	$77.85 - $96.01 $42,350 - $52,229	544 Added 8.5%	6,947 $640,000
Q3 2018 Oct 19, 2018	SELL	$88.91 - $98.84 $10,224 - $11,366	-115 Reduced 1.76%	6,403 $606,000
Q2 2018 Jul 06, 2018	SELL	$89.78 - $106.23 $6,733 - $7,967	-75 Reduced 1.14%	6,518 $604,000
Q3 2017 Oct 06, 2017	BUY	$69.85 - $89.22 $460,521 - $588,227	6,593	6,593 $586,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $306B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abner Herrman & Brock LLC, based on Form 13F filings with the SEC.

News

Stay updated on Abner Herrman & Brock LLC with notifications on news.

Account

Abner Herrman & Brock LLC Abb Vie Inc. Transaction History